Department of Orthopedics (Spine Special), Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, Yunnan 650118, P.R. China.
Department of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, Yunnan 650118, P.R. China.
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8334. Epub 2022 May 20.
The in‑depth study of melanoma pathogenesis has revealed that epigenetic modifications, particularly DNA methylation, is a universal inherent feature of the development and progression of melanoma. In the present study, the analysis of the tumor suppressor gene growth arrest‑specific transcript 5 (GAS5) demonstrated that its expression was downregulated in melanoma, and its expression level had a certain negative association with its methylation modification level. The promoter of GAS5 presented with detectable CpG islands, and methylation‑specific polymerase chain reaction analysis demonstrated that GAS5 was actually modified by methylation in melanoma tissues and cells; however, no methylation modification of GAS5 was detected in normal tissues. Following the treatment of melanoma cells with 5‑Aza‑2'‑deoxycytidine (5‑Aza‑dC), GAS5 methylation was significantly reversed. The analysis of melanoma cell proliferation revealed that 5‑Aza‑dC inhibited A375 and SK‑MEL‑110 cell proliferation in a time‑dependent manner. Further analysis of apoptosis demonstrated that 5‑Aza‑dC significantly increased the apoptosis level of the two cell lines. Moreover, migration analysis of melanoma cells revealed that 5‑Aza‑dC significantly reduced cell migration. Furthermore, 5‑Aza‑dC significantly decreased the invasive ability of the two cell lines. However, when the expression of GAS5 was silenced, the effects of 5‑Aza‑dC on cell proliferation, apoptosis, invasion and migration were not significant. Furthermore, the subcutaneous injection of A375 cells in nude mice successfully resulted in xenograft tumor formation. However, following an intraperitoneal injection of 5‑Aza‑dC, the volume and weight of xenograft tumors and Ki‑67 expression were significantly reduced, and caspase‑3 activity and GAS5 expression were enhanced; following the silencing of GAS5, the antitumor effect of 5‑Aza‑dC was significantly blocked. On the whole, the present study demonstrates that 5‑Aza‑dC inhibits the growth of melanoma, and its function may be related to the methylation modification of GAS5.
黑色素瘤发病机制的深入研究表明,表观遗传修饰,特别是 DNA 甲基化,是黑色素瘤发生和发展的普遍固有特征。本研究分析肿瘤抑制基因生长停滞特异性转录物 5(GAS5)表明,其在黑色素瘤中表达下调,其表达水平与甲基化修饰水平呈一定负相关。GAS5 的启动子呈现可检测的 CpG 岛,甲基化特异性聚合酶链反应分析表明 GAS5 在黑色素瘤组织和细胞中确实被甲基化修饰;然而,在正常组织中未检测到 GAS5 的甲基化修饰。用 5-氮杂-2'-脱氧胞苷(5-Aza-dC)处理黑色素瘤细胞后,GAS5 甲基化明显逆转。分析黑色素瘤细胞增殖发现,5-Aza-dC 呈时间依赖性抑制 A375 和 SK-MEL-110 细胞增殖。进一步分析凋亡表明,5-Aza-dC 显著增加了这两种细胞系的凋亡水平。此外,黑色素瘤细胞迁移分析表明,5-Aza-dC 显著降低了细胞迁移。此外,5-Aza-dC 显著降低了这两种细胞系的侵袭能力。然而,当 GAS5 的表达被沉默时,5-Aza-dC 对细胞增殖、凋亡、侵袭和迁移的影响并不显著。此外,在裸鼠中皮下注射 A375 细胞成功导致异种移植肿瘤形成。然而,腹腔注射 5-Aza-dC 后,异种移植肿瘤的体积和重量以及 Ki-67 表达明显减少,caspase-3 活性和 GAS5 表达增强;沉默 GAS5 后,5-Aza-dC 的抗肿瘤作用明显受阻。总的来说,本研究表明 5-Aza-dC 抑制黑色素瘤生长,其功能可能与 GAS5 的甲基化修饰有关。